ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

Decision On Status Of Frederickson, DeVita Due In Month, Schweiker Says

May 1, 1981

Newell Reports Cancer Deaths In Younger Age Groups Dropping

March 18, 1977

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

North Central Group Review Postponed While New Committee Formed To Handle All “Regional: Groups

July 10, 1981